BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-377@pharmaconomics
DTSTAMP:20260707T025207Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:GRTX Phase 3 — OBX-115 (estimated date)
DESCRIPTION:Phase 3 trial results for OBX-115 in melanoma are due ~ Dec 31\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1563577/000119312526154009/d124753dex992.htm\n\nTrack it: https://pharmaconomics.com/e/377
URL:https://pharmaconomics.com/e/377
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:GRTX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR